Story at-a-glance

  • Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, favors using remdesivir, despite a lack of science-based evidence of it being effective against COVID-19
  • The antiviral prodrug is a nucleoside/nucleotide reverse transcriptase inhibitor and a close cousin to the HIV drug tenofovir used to fight the retrovirus that triggers AIDS
  • Although trials with remdesivir do not back the general claims from Fauci that the drug is “highly significant” and the “new standard of care,” general approval by the FDA was given in October 2020, which boosted first quarter sales for its maker
  • Conversely, ivermectin, a long-used antiparasitic drug with a known profile of safety, is effective against the virus but information is being suppressed as fear strategies are used to funnel the public into vaccination programs


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *